Talinexomer
- Generic Name
- Talinexomer
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Sorbent Therapeutics
- Target Recruit Count
- 270
- Registration Number
- NCT01736735
- Locations
- 🇺🇸
Orange Country Research Center, Tustin, California, United States
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2013-07-19
- Lead Sponsor
- Sorbent Therapeutics
- Target Recruit Count
- 18
- Registration Number
- NCT01598740
- Locations
- 🇺🇸
Orange Country Research Center, Tustin, California, United States
Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2013-03-13
- Lead Sponsor
- Sorbent Therapeutics
- Target Recruit Count
- 113
- Registration Number
- NCT01265524
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath